1 Product identity
Ingredient risk
Contains a high-risk ingredient
Evolution 60
BrandExeltis USA→Other Combinations Powder 17 ingredients 1 high-risk 1 caution DSLD #208914Net contents: 60 Packet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2019-11-21
2 Ingredients (17)
IngredientGroupSafety
CaloriesCalories—
Total CarbohydratesCarbohydrate—
SugarSugar—
SucroseSucrose—
Citric AcidCitric Acid—
Artificial flavorFlavor—
Fatty Acid Sucrose EsterSucrose ester—
Acesulfame KAcesulfame potassium—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Inositol — GDM prevention — 4 g/day from first trimester in high-risk women [2]
⚠️ Use with caution — restricted in some markets
Aspartame 🇪🇺 — e (1981). ADI: 50 mg/kg/day (higher than EU). PKU warning label mandatory [1]. || European Union (EFSA) :: Approved as E
3 Safety cross-reference
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Inositol — High risk
⚠ GI disturbance at high doses (>12 g)
⚠ May lower blood glucose
L-Carnitine — Generally Safe
⚠ Fishy body odor
⚠ TMAO concern
L-Arginine — Limited Evidence
⚠ Hypotension
⚠ May worsen herpes outbreaks
Aspartame — Use with Caution
⚠ WHO/IARC 2023: Group 2B (possibly carcinogenic)
⚠ Headache/migraine trigger in sensitive individuals
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID208914
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2019-11-21
6 More from Exeltis USA
View Exeltis USA Safety Scorecard → 3 products
DHA Softgel CapsuleVitafol-OB Caplet7 Cite this page
Vancouver
Pkhakadze G. Evolution 60 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/evolution-60-208914/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG